Numerai GP LLC Sells 26,599 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Numerai GP LLC cut its position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 55.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,421 shares of the financial services provider's stock after selling 26,599 shares during the quarter. Numerai GP LLC owned 0.05% of Trupanion worth $1,032,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Amundi boosted its stake in Trupanion by 193.2% in the 4th quarter. Amundi now owns 16,828 shares of the financial services provider's stock worth $784,000 after purchasing an additional 11,088 shares during the period. Barclays PLC boosted its position in shares of Trupanion by 259.2% in the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock worth $2,750,000 after buying an additional 47,262 shares during the period. Vanguard Group Inc. grew its holdings in shares of Trupanion by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock valued at $173,362,000 after buying an additional 45,653 shares in the last quarter. Wealthfront Advisers LLC purchased a new position in shares of Trupanion during the fourth quarter valued at $845,000. Finally, Dimensional Fund Advisors LP raised its position in Trupanion by 112.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock valued at $13,204,000 after buying an additional 144,828 shares during the period.

Wall Street Analyst Weigh In

Several research firms have weighed in on TRUP. Lake Street Capital dropped their price objective on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Piper Sandler cut their price objective on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Finally, Stifel Nicolaus decreased their target price on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $51.80.

Insider Transactions at Trupanion

In other news, CFO Fawwad Qureshi sold 1,373 shares of Trupanion stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the transaction, the chief financial officer now directly owns 2,416 shares in the company, valued at approximately $82,675.52. The trade was a 36.24% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Margaret Tooth sold 2,294 shares of the company's stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total value of $72,008.66. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at $3,728,629.76. The trade was a 1.89% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,792 shares of company stock worth $1,122,802 in the last 90 days. Corporate insiders own 5.42% of the company's stock.

Trupanion Trading Down 1.3%

Shares of TRUP traded down $0.62 on Tuesday, reaching $45.53. 93,042 shares of the company's stock were exchanged, compared to its average volume of 611,798. The business has a 50 day moving average price of $38.21 and a two-hundred day moving average price of $44.13. Trupanion, Inc. has a 12 month low of $25.90 and a 12 month high of $57.90. The stock has a market capitalization of $1.95 billion, a P/E ratio of -197.85, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. The business had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. Trupanion's quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.16) EPS. Research analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.